ArticleThe FEBS journal2025

The AXL inhibitor bemcentinib overcomes microenvironment-mediated resistance to pioglitazone in acute myeloid leukemia.

Jaja Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.